PH16249A - Imidazoline derivatives,its pharmaceutical composition and method of use - Google Patents

Imidazoline derivatives,its pharmaceutical composition and method of use

Info

Publication number
PH16249A
PH16249A PH25123A PH25123A PH16249A PH 16249 A PH16249 A PH 16249A PH 25123 A PH25123 A PH 25123A PH 25123 A PH25123 A PH 25123A PH 16249 A PH16249 A PH 16249A
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
imidazoline derivatives
imidazoline
derivatives
pharmaceutical
Prior art date
Application number
PH25123A
Other languages
English (en)
Inventor
Christopher Bourne Chapleo
Peter Leslie Myers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of PH16249A publication Critical patent/PH16249A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH25123A 1980-02-04 1981-01-22 Imidazoline derivatives,its pharmaceutical composition and method of use PH16249A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8003636 1980-02-04

Publications (1)

Publication Number Publication Date
PH16249A true PH16249A (en) 1983-08-16

Family

ID=10511105

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25123A PH16249A (en) 1980-02-04 1981-01-22 Imidazoline derivatives,its pharmaceutical composition and method of use

Country Status (26)

Country Link
US (1) US4818764A (hu)
EP (1) EP0033655B1 (hu)
JP (1) JPS56122378A (hu)
AR (1) AR225794A1 (hu)
AT (1) ATE7228T1 (hu)
AU (1) AU535320B2 (hu)
CA (1) CA1156241A (hu)
CS (1) CS254956B2 (hu)
DD (1) DD155991A5 (hu)
DE (1) DE3163256D1 (hu)
DK (1) DK160092C (hu)
ES (1) ES8202553A1 (hu)
FI (1) FI67543C (hu)
GB (1) GB2068376B (hu)
GR (1) GR73853B (hu)
HU (1) HU187295B (hu)
IE (1) IE51736B1 (hu)
IL (1) IL62039A (hu)
NO (1) NO154882C (hu)
NZ (1) NZ196162A (hu)
PH (1) PH16249A (hu)
PL (1) PL128368B1 (hu)
PT (1) PT72435B (hu)
SU (1) SU1128837A3 (hu)
ZA (1) ZA81666B (hu)
ZW (1) ZW2381A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
FR2527208B1 (fr) * 1982-05-19 1985-07-19 Inst Nat Sante Rech Med Isomeres optiques de la (benzodioxanne-1,4 yl-2)-2d-2 imidazoline, leur preparation et leur application en therapeutique
ATE23337T1 (de) * 1982-12-23 1986-11-15 Ici America Inc Chromanverbindungen.
US4634714A (en) * 1983-12-01 1987-01-06 American Home Products Corporation Inhibition of prolactin release by a benzodioxinylimidazoline derivative
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
GB8720600D0 (en) * 1987-09-02 1987-10-07 Saad Al Damluji Pharmaceutical compositions
US5240930A (en) * 1987-09-02 1993-08-31 National Research Development Corporation Pharmaceutical compositions for treatment of depression and low blood pressure
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US5574059A (en) * 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
FR2801786B1 (fr) * 1999-12-01 2002-03-01 Fabre Pierre Cosmetique Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite
AU2001243297A1 (en) * 2000-02-29 2001-09-12 Merck Frosst Canada And Co. Method for treating or preventing depression
FR2861299B1 (fr) * 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
US7595335B2 (en) * 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US8476307B2 (en) * 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
WO2023159145A1 (en) * 2022-02-16 2023-08-24 Terran Biosciences, Inc. Deuterated idazoxan and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641601A (en) * 1950-11-24 1953-06-09 Hoffmann La Roche Furans and method of preparation
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
JPS5276346A (en) * 1975-12-22 1977-06-27 Sumitomo Bakelite Co Ltd Epoxy resin adhesive composition
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4302469A (en) * 1980-09-10 1981-11-24 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
US4301171A (en) * 1980-12-03 1981-11-17 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)benzimidazoles useful as anti-depressants
US4315021A (en) * 1980-12-03 1982-02-09 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Also Published As

Publication number Publication date
PL128368B1 (en) 1984-01-31
EP0033655A2 (en) 1981-08-12
DK45081A (da) 1981-08-05
DE3163256D1 (en) 1984-05-30
GR73853B (hu) 1984-05-07
NO154882C (no) 1987-01-07
ATE7228T1 (de) 1984-05-15
SU1128837A3 (ru) 1984-12-07
GB2068376A (en) 1981-08-12
DK160092C (da) 1991-06-24
NO154882B (no) 1986-09-29
PT72435B (pt) 1982-01-29
ZW2381A1 (en) 1981-06-24
JPS56122378A (en) 1981-09-25
US4818764A (en) 1989-04-04
HU187295B (en) 1985-12-28
AU535320B2 (en) 1984-03-15
ES499034A0 (es) 1982-02-01
CA1156241A (en) 1983-11-01
IE51736B1 (en) 1987-03-18
NZ196162A (en) 1983-06-17
AR225794A1 (es) 1982-04-30
DD155991A5 (de) 1982-07-21
DK160092B (da) 1991-01-28
ZA81666B (en) 1982-04-28
ES8202553A1 (es) 1982-02-01
CS73881A2 (en) 1987-07-16
IE810199L (en) 1981-08-04
CS254956B2 (en) 1988-02-15
IL62039A (en) 1985-01-31
FI67543C (fi) 1985-04-10
IL62039A0 (en) 1981-03-31
FI67543B (fi) 1984-12-31
AU6675881A (en) 1981-08-13
EP0033655A3 (en) 1981-11-25
EP0033655B1 (en) 1984-04-25
PL229488A1 (hu) 1981-10-16
GB2068376B (en) 1983-06-22
NO810351L (no) 1981-08-05
JPH0231077B2 (hu) 1990-07-11
PT72435A (en) 1981-03-01
FI810288L (fi) 1981-08-05

Similar Documents

Publication Publication Date Title
PH15719A (en) Aminoalkylbenzoic derivatives,pharmaceutical composition and method of use
PH22672A (en) Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
PH20243A (en) Cephalosporin derivatives, pharmaceutical formulation containing same and method of use thereof
PH16249A (en) Imidazoline derivatives,its pharmaceutical composition and method of use
PH18979A (en) Banzazepine derivatives,their pharmaceutical compositions and method of use
PH21029A (en) Benzene derivatives, pharmaceutical compositions and method of use thereof
CS410491A3 (en) Heterocyclic derivatives, process of their preparation and pharmaceutical containing them
DE3062586D1 (en) 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same
PH23341A (en) Morphinane derivatives,pharmaceutical composition containing said compounds and method of use thereof
IL64146A0 (en) Derivatives of thieno-pyridinone,the method of their preparation and their therapeutic use
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
PH19005A (en) Penicillanic acid derivatives,pharmaceutical compositions containing the same and method of use thereof
PT73061B (en) Process for the preparation of new derivatives of taurina and its pharmaceutical use
DE3277838D1 (en) Thiazolylurea derivatives, process for their preparation, and medicinal composition containing same
DE3262919D1 (en) Imidazoline derivatives, process for the preparation thereof, pharmaceutical compositions containing them and their use
PH19347A (en) Triazole derivatives,pharmaceutical composition containing same and method of use thereof
DE3176402D1 (en) Benzazol derivatives, processes for their preparation, their pharmaceutical composition and their application
PH16128A (en) Benzodiazepine derivatives,their pharmaceutical composition and method of use
EP0058079A3 (en) Imidazole derivative, method of preparation thereof, and pharmaceutical composition containing same
PH16860A (en) Novel indane derivatives,pharmaceutical compositions containing said derivatives and method of use thereof
EP0084190A3 (en) Medicinal composition, package and method of making the composition
PH14064A (en) Phenylgycine derivatives,pharmaceutical compositions and method of use
PH14835A (en) Isoquinoline derivatives,their composition and method of use
PH22247A (en) Diazepinoindole, pharmaceutical composition and method of use thereof
DE2860561D1 (en) Method for the continuous preparation of hydantoin derivatives, and apparatus for the application thereof